Literature DB >> 20528447

Understanding and overcoming major barriers in cancer nanomedicine.

Shuming Nie.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20528447      PMCID： PMC2913868          DOI： 10.2217/nnm.10.23

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  51 in total

1.  The use of nanocrystals in biological detection.

Authors:  Paul Alivisatos
Journal:  Nat Biotechnol       Date:  2004-01       Impact factor: 54.908

Review 2.  Parameters influencing the stealthiness of colloidal drug delivery systems.

Authors:  Arnaud Vonarbourg; Catherine Passirani; Patrick Saulnier; Jean-Pierre Benoit
Journal:  Biomaterials       Date:  2006-05-02       Impact factor: 12.479

3.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

4.  Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung.

Authors:  Phil Oh; Per Borgström; Halina Witkiewicz; Yan Li; Bengt J Borgström; Adrian Chrastina; Koji Iwata; Kurt R Zinn; Richard Baldwin; Jacqueline E Testa; Jan E Schnitzer
Journal:  Nat Biotechnol       Date:  2007-03-04       Impact factor: 54.908

Review 5.  Nanotechnology and cancer.

Authors:  James R Heath; Mark E Davis
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

6.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Martina Foy; Tord Berggård; Seamas C Donnelly; Gerard Cagney; Sara Linse; Kenneth A Dawson
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 7.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

Review 8.  Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.

Authors:  R K Jain
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

9.  Does a targeting ligand influence nanoparticle tumor localization or uptake?

Authors:  Kathleen F Pirollo; Esther H Chang
Journal:  Trends Biotechnol       Date:  2008-08-21       Impact factor: 19.536

10.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701
View more
  95 in total

1.  Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties.

Authors:  Neha B Shah; Gregory M Vercellotti; James G White; Adrian Fegan; Carston R Wagner; John C Bischof
Journal:  Mol Pharm       Date:  2012-07-23       Impact factor: 4.939

Review 2.  Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.

Authors:  Jie Wang; Ze Lu; Yue Gao; M Guillaume Wientjes; Jessie L-S Au
Journal:  Nanomedicine (Lond)       Date:  2011-11       Impact factor: 5.307

3.  Controlled cell death by magnetic hyperthermia: effects of exposure time, field amplitude, and nanoparticle concentration.

Authors:  L Asín; M R Ibarra; A Tres; G F Goya
Journal:  Pharm Res       Date:  2012-02-24       Impact factor: 4.200

4.  Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles.

Authors:  Ying Li; Yanping Lian; Lucy T Zhang; Saad M Aldousari; Hassan S Hedia; Saeed A Asiri; Wing Kam Liu
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

5.  Diosgenin-loaded niosome as an effective phytochemical nanocarrier: physicochemical characterization, loading efficiency, and cytotoxicity assay.

Authors:  Mohammad Reza Hajizadeh; Najmeh Parvaz; Mahmood Barani; Alireza Khoshdel; Mohammad Ali Fahmidehkar; Mehdi Mahmoodi; Masoud Torkzadeh-Mahani
Journal:  Daru       Date:  2019-05-27       Impact factor: 3.117

6.  Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors.

Authors:  Samdeep K Mouli; Patrick Tyler; Joseph L McDevitt; Aaron C Eifler; Yang Guo; Jodi Nicolai; Robert J Lewandowski; Weiguo Li; Daniel Procissi; Robert K Ryu; Y Andrew Wang; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  ACS Nano       Date:  2013-08-20       Impact factor: 15.881

7.  MR imaging enables measurement of therapeutic nanoparticle uptake in rat N1-S1 liver tumors after nanoablation.

Authors:  Joseph L McDevitt; Samdeep K Mouli; Patrick D Tyler; Weiguo Li; Jodi Nicolai; Daniele Procissi; Ann B Ragin; Y Andrew Wang; Robert J Lewandowski; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2014-05-20       Impact factor: 3.464

Review 8.  Nano-engineered delivery systems for cancer imaging and therapy: Recent advances, future direction and patent evaluation.

Authors:  Ghazal Nabil; Ketki Bhise; Samaresh Sau; Mohamed Atef; Hossny A El-Banna; Arun K Iyer
Journal:  Drug Discov Today       Date:  2018-08-16       Impact factor: 7.851

9.  Delivery of siRNA silencing Runx2 using a multifunctional polymer-lipid nanoparticle inhibits osteogenesis in a cell culture model of heterotopic ossification.

Authors:  Swati Mishra; Asa D Vaughn; David I Devore; Charles M Roth
Journal:  Integr Biol (Camb)       Date:  2012-12       Impact factor: 2.192

10.  Evidences For Charge Transfer-Induced Conformational Changes In Carbon Nanostructure-Protein Corona.

Authors:  R Podila; P Vedantam; P C Ke; J M Brown; A M Rao
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2012-09-26       Impact factor: 4.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.